Developing a more effective compression therapy device that can better prevent Venous thromboembolism (VTE) in patients and reduce the use of expensive and risky anti-coagulation pharmaceuticals.

OsciFlex’s system imitates nature’s process to prevent deadly blood clots.

Designed to protect immobile hospital patients by providing the benefits of ambulation (including muscle stimulation) using passive motion.

Venous thromboembolism (VTE) is a leading cause of complications and death for hospitalized patients. Prevention is a national priority.

The innovative design of the system is based off a novel discovery of the root cause of VTE.

Industry: Health
Status: Active

Contact Information

https://osciflex.com/

John Welsh

founder and CEO

Robert Edelstein

Chief Business Development Officer